HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yolk sac tumor with a unique uniform hepatoid pattern histology.

AbstractBACKGROUND:
Yolk sac tumors (YST) exhibit several different histological subtypes and the mechanisms of cellular differentiation and prognosis of each subtype remain unknown.
RESULTS:
We report two infants with sacrococcygeal YST; one represented a typical histological subtype and the other showed a hepatoid subtype with uniform histology. The isoform of alpha-fetoprotein (AFP) in the patient with the hepatoid pattern was examined by lectin-affinity immunoelectrophoresis and represented as a YST, but not hepatocellular, subtype. The patient with typical YST responded well to VAB-6 combination chemotherapy. However, this regimen was only partially effective to the patient with the pure hepatoid histological subtype, and an etoposide with ifosfamide and cisplatin (VIP) regimen as a salvage chemotherapy combined with complete tumor resection was useful to achieve complete remission (CR). Both of the patients have been in CR for more than four years.
AuthorsA Konno, M Kudo, T Ichihara, M Yamagami, S Horita, K Ohama, K Taketa, S Koizumi
JournalActa paediatrica Japonica : Overseas edition (Acta Paediatr Jpn) Vol. 40 Issue 5 Pg. 466-9 (Oct 1998) ISSN: 0374-5600 [Print] Australia
PMID9821708 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Protein Isoforms
  • alpha-Fetoproteins
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Child, Preschool
  • Combined Modality Therapy
  • Endodermal Sinus Tumor (blood, pathology, therapy)
  • Female
  • Humans
  • Infant
  • Protein Isoforms
  • Sacrococcygeal Region
  • Salvage Therapy
  • Treatment Outcome
  • alpha-Fetoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: